SEVERE NEUROTOXICITY FOLLOWING HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND THIOTEPA IN THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA: THE UK EXPERIENCE

被引:0
|
作者
Hayden, J. [1 ]
Vivekanandan, S. [2 ]
Thorp, N. [3 ]
Mayles, H. [4 ]
Baker, A. [4 ]
Pizer, B. [1 ]
Horan, G. [5 ]
机构
[1] Alder Hey Childrens NHS Fdn Trust, Paediat Oncol, Liverpool, Merseyside, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Paediat Oncol, Cambridge, England
[3] Clatterbridge Canc Ctr NHS Fdn Trust, Oncol, Wirral, Merseyside, England
[4] Clatterbridge Canc Ctr NHS Fdn Trust, Clin Radiotherapy, Wirral, Merseyside, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Clin Oncol, Cambridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-105
引用
收藏
页码:S172 / S173
页数:2
相关论文
共 50 条
  • [21] Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: Therapeutic efficacy and neurotoxicity
    Waber, DP
    Silverman, LB
    Catania, L
    Mautz, W
    Rue, M
    Gelber, RD
    Levy, DE
    Goldwasser, MA
    Adams, H
    Dufresne, A
    Metzger, V
    Romero, I
    Tarbell, NJ
    Dalton, VK
    Sallan, SE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2701 - 2707
  • [22] Hyperfractionated accelerated radiotherapy (HART) and intensive postoperative chemotherapy for the treatment of metastatic medulloblastoma: Long-term results of the milan strategy
    Gandola, Lorenza
    Massimino, Maura
    Pecori, Emilia
    Spreafico, Filippo
    Berretta, Serena
    Pignoli, Emanuele
    Cefalo, Graziella
    Luksch, Roberto
    Poggi, Geraldina
    Ferrari, Andrea
    Casanova, Michela
    Terenziani, Monica
    Bellani, Franca Fossati
    NEURO-ONCOLOGY, 2008, 10 (03) : 480 - 480
  • [23] Thiotepa-based High-dose Chemotherapy with Autologous Stem Cell Rescue in Children with High-risk Medulloblastoma
    Sajiki, Daichi
    Maemura, Ryo
    Yamamori, Ayako
    Wakamatsu, Manabu
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hatano, Hisashi
    Kato, Koji
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S55 - S55
  • [24] Delayed-accelerated hyperfractionated radiation therapy for advanced-stage or high-risk rhabdomyosarcoma
    Merchant, TE
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (01): : 45 - 50
  • [25] HIGH DOSE ACCELERATED HYPERFRACTIONATED RADIOTHERAPY IN THE TREATMENT OF LIMITED STAGE SMALL CELL LUNG CANCER
    Skripchak, Y.
    Valkov, M.
    Asakhin, S.
    Kononova, G.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S342 - S342
  • [26] Temozolomide in the management of high-risk medulloblastoma/PNET:: A promising pilot experience
    Fruehwald, M. C.
    Juergens, H.
    Paulus, W.
    Straeter, R.
    NEURO-ONCOLOGY, 2007, 9 (02) : 190 - 190
  • [27] Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
    Gringmuth, Marieke
    Walther, Jenny
    Greiser, Sebastian
    Toussaint, Magali
    Schwalm, Benjamin
    Kool, Marcel
    Kortmann, Rolf-Dieter
    Glasow, Annegret
    Patties, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [28] Adjuvant treatment with concomitant radiotherapy, and chemotherapy in high-risk endometrial cancer: A clinical experience
    De Marzi, Patrizia
    Frigerio, Luigi
    Cipriani, Sonia
    Parazzini, Fabio
    Busci, Luisa
    Carlini, Laura
    Vigano, Riccardo
    Mangili, Giorgia
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 408 - 412
  • [29] Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery
    Kushner, BH
    Wolden, S
    LaQuaglia, MP
    Kramer, K
    Verbel, D
    Heller, G
    Cheung, NKV
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2821 - 2828
  • [30] Locoregional Control Following Adjuvant Chemotherapy and Radiotherapy for Treatment of High-Risk Endometrial Cancer
    Babadagli, E.
    Kulkarni, A.
    Le, T.
    Fung-Kee-Fung, M.
    Lupe, K.
    Gaudet, M.
    Samant, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E269 - E270